GLP-1 receptor agonists, offering clinically proven and durable weight-loss outcomes, are thus positioned to capture expanding demand in obesity management, driving market growth globally and complementing their use in diabetes care
Since many GLP-1 medications facilitate substantial weight reduction, distinguishing between direct anti-inflammatory effects and those mediated by weight loss presents a methodological challenge
32 Included patients were matched for age, sex, race and ethnicity, cardiovascular diseases, DR severity (including PDR and DME status), history of tobacco use, body mass index, and hemoglobin A1c percentage
Teaming Up with a Dietitian: Your Personal Health Coach Changing how you eat or live can feel overwhelminglike trying to solve a puzzle with missing pieces
Future studies should continue to explore the dual mechanism of action of GLP-1R in metabolism and the nervous system, especially its potential applications at the intersection of AD and DM
